Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead.


Journal

Current diabetes reviews
ISSN: 1875-6417
Titre abrégé: Curr Diabetes Rev
Pays: United Arab Emirates
ID NLM: 101253260

Informations de publication

Date de publication:
2021
Historique:
received: 02 05 2020
revised: 15 10 2020
accepted: 20 10 2020
pubmed: 5 11 2020
medline: 28 5 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Diabetic foot ulcer (DFU) is one of the leading complications of type-2 diabetes mellitus. It is associated with neuropathy and peripheral arterial disease of the lower limb in patients with diabetes. There are four stages of wound healing, namely hemostasis phase, inflammatory phase, proliferative phase and maturation phase. In the case of DFU, all these stages are disturbed which lead to delay in healing and consequently to lower limb amputation. Conventional dosage forms like tablets, creams, ointments, gels and capsules have been used for the treatment of diabetic foot ulcer for many years. In this review, the global prevalence as well as etiopathogenesis related to diabetic foot ulcer have been discussed. The potential role of various synthetic and herbal drugs, as well as their conventional dosage forms in the effective management of DFU have been discussed in detail. Structured search of bibliographic databases from previously published peer-reviewed research papers was explored and data has been represented in terms of various approaches that are used for the treatment of DFU. About 148 papers, including both research and review articles, were included in this review to produce a comprehensive as well as a readily understandable article. A series of herbal and synthetic drugs have been discussed along with their current status of treatment in terms of dose and mechanism of action. DFU has become one of the most common complications in patients having diabetes for more than ten years. Hence, understanding the root cause and its successful treatment is a big challenge because it depends upon multiple factors such as the judicious selection of drugs as well as proper control of blood sugar level. Most of the drugs that have been used so far either belong to the category of antibiotics, antihyperglycaemic or they have been repositioned. In clinical practice, much focus has been given to dressings that have been used to cover the ulcer. The complete treatment of DFU is still a farfetched dream to be achieved and it is expected that combination therapy of herbal and synthetic drugs with multiple treatment pathways could be able to offer better management of DFU.

Sections du résumé

BACKGROUND BACKGROUND
Diabetic foot ulcer (DFU) is one of the leading complications of type-2 diabetes mellitus. It is associated with neuropathy and peripheral arterial disease of the lower limb in patients with diabetes. There are four stages of wound healing, namely hemostasis phase, inflammatory phase, proliferative phase and maturation phase. In the case of DFU, all these stages are disturbed which lead to delay in healing and consequently to lower limb amputation. Conventional dosage forms like tablets, creams, ointments, gels and capsules have been used for the treatment of diabetic foot ulcer for many years.
INTRODUCTION BACKGROUND
In this review, the global prevalence as well as etiopathogenesis related to diabetic foot ulcer have been discussed. The potential role of various synthetic and herbal drugs, as well as their conventional dosage forms in the effective management of DFU have been discussed in detail.
METHODS METHODS
Structured search of bibliographic databases from previously published peer-reviewed research papers was explored and data has been represented in terms of various approaches that are used for the treatment of DFU.
RESULTS RESULTS
About 148 papers, including both research and review articles, were included in this review to produce a comprehensive as well as a readily understandable article. A series of herbal and synthetic drugs have been discussed along with their current status of treatment in terms of dose and mechanism of action.
CONCLUSION CONCLUSIONS
DFU has become one of the most common complications in patients having diabetes for more than ten years. Hence, understanding the root cause and its successful treatment is a big challenge because it depends upon multiple factors such as the judicious selection of drugs as well as proper control of blood sugar level. Most of the drugs that have been used so far either belong to the category of antibiotics, antihyperglycaemic or they have been repositioned. In clinical practice, much focus has been given to dressings that have been used to cover the ulcer. The complete treatment of DFU is still a farfetched dream to be achieved and it is expected that combination therapy of herbal and synthetic drugs with multiple treatment pathways could be able to offer better management of DFU.

Identifiants

pubmed: 33143613
pii: CDR-EPUB-111085
doi: 10.2174/1573399816999201102125537
doi:

Substances chimiques

Hypoglycemic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-436

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Ankit Awasthi (A)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Sachin Kumar Singh (SK)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Bimlesh Kumar (B)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Monica Gulati (M)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Rajesh Kumar (R)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Sheetu Wadhwa (S)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Rubiya Khursheed (R)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Leander Corrie (L)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Arya Kr (A)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Rajan Kumar (R)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Pooja Patni (P)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Jaskiran Kaur (J)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Sukriti Vishwas (S)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Ankit Yadav (A)

School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH